Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers

This study was a phase 1, single-center, randomized, double-blind, placebo-controlled, single-dosing, and dose-escalating study of intravenous SAL200. It is a new candidate drug for the treatment of antibiotic-resistant staphylococcal infections based on a recombinant form of the phage endolysin SAL...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, Soo Youn, Jang, In Jin, Yoon, Seonghae, Jang, Kyungho, Yu, Kyung-Sang, Cho, Joo Youn, Seong, Moon-Woo, Jung, Gi Mo, Yoon, Seong Jun, Kang, Sang Hyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444177/
https://www.ncbi.nlm.nih.gov/pubmed/28348152
http://dx.doi.org/10.1128/AAC.02629-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444177/
https://www.ncbi.nlm.nih.gov/pubmed/28348152
http://dx.doi.org/10.1128/AAC.02629-16

Ejemplares similares